No Detail Found!

Computational Analysis of Pen-110 Binding to Cd-61 of Platelets.

Author(s)
Hammad Tufail Chaudhary Department of Pathology, Medical College, Taif University, Saudi Arabia
Abstract
OBJECTIVE: To review the docking of PEN-110 at CD-61 which would give the idea about the effect of PEN-110 on function of platelets. STUDY DESIGN: An observational study. PLACE AND DURATION: At Medical College, Taif University, Taif, Saudi Arabia from March 1st, 2016 to September 30th, 2016. METHODOLOGY: The study was carried out in-silico. PDB (Protein data bank) code of Tirofiban bound to CD-61 was 2vdm. CD-61 (2vdm) was docked with Tirofiban as a control using online docking tools i.e.Patchdock and Firedock. Then, PEN-110 and CD-61 were also docked together. Best docking poses and their interactions to active sites of 2vdm were found. Then comparison of Hydrogen Bonds, Hydrogen Bond Lengths, Hydrophobic bonds of 2vdm molecule and best poses of docking results were done. RESULTS: The Hydrogen bonds and Hydrogen bond length and Hydrophobic bonds of docking results were compared to 2vdm. No docking to active site was observed in Patchdock. In firedock docking, PEN-110 docked to active site of CD61, but the global energy of docking was significantly less than the global energy of binding of Tirofiban with CD61 i.e. 101.9 in comparison to -5.99, respectively. CONCLUSION: PEN-110 binds to the active site of CD-61 with weaker binding force. We can establish that PEN-110 does not affect this important receptor of platelet which is needed for proper function of platelets.
Publication Details
Page(s) 324-328
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 9, Issue: 5, Year: 2017

Request the full text from PASTIC

References
AndradeRG,RibeiroMA,Namen-LopesMS,SilvaSM,BasquesFV,RibasJG, 2010.Evaluation of the use of realtime PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors,Rev Soc Bras Med Trop 43 111 -15
AcarA,KemahliS,AltunayH,KosanE,OnculO,GorenekL, 2010.HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies?,Bra J Inf Dis 14 41 -46
MontagT., 2008.Strategies of bacteria screening in cellular blood components,Clin Chem Lab Med 46 926 -32
PalavecinoE,YomtovianR, 2003.Risk and prevention of transfusion-related sepsis,Curr Opin Hematol 10 434 -39
SusanneM., 2013.Current methods for the reduction of bloodborne pathogens:a comprehensive literature review,Blood Transfus 11 343 -48
Schlenke P. Pathogen, 2014.Inactivation Technologies for Cellular Blood Components: an Update,Transfus Med Hemother 41 309 -25
ChaudharyHT, 2017.Blood Bag's protection from bacteria: Review,Prof Med 24 210 -15
SobralPM,BarrosAE,GomesAM,BonfimCV, 2012.Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids,Rev Bras Hematol Hemoter 34 231 -35
SpringerTA,ZhuJ,XiaoT., 2008.Structural basis for distinctive recognition of fi brinogen γC peptide by the platelet integrin αIIbβ3,J Cell Biol 182 791 -800
ChaudharyHT,HasnainS.,In-SilicoAnalysis, 2016.Analysis Of S303 Binding To CD-61 Of Platelets,Prof Med 23 217 -22
ChaudharyHT, 2016.In-silico analysis of Amotosalen Hydrochloride binding to CD-61 of platelets,J Coll Phys Surg Pak 26 881 -86
Schneidman-DuhovnyD,InbarY,NussinovR,WolfsonHJ, 2005.PatchDock and SymmDock: servers for rigid and symmetric docking,Nucleic Acids Res 33 363 -67
MashiachE,Schneidman-DuhovnyD,AndrusierN,NussinovR,WolfsonHJ, 2008.FireDock: a web server for fast interaction refinement in molecular docking,Nucleic Acids Res 36 229 -32
EpsteinJS,VostalJG, 2003.FDA approach to evaluation of pathogen reduction technology,Transfusion 43 1347 -50
SpringerTA,ZhuJ,XiaoT, 2008.Structural Basis for Distinctive Recognition of Fibrinogen Gammac Peptide by the Platelet Integrin Alphaiibbeta3,J Cell Biol 182 791 -
Spain: DeLano ScientificLLC, 2006., -
SA, .Website:,Biotechnology Information; 2006 July 30 -
EMBL-EBI, 1992., -
EMBL-EBI, 1992.Protein Data Bank in Europe, -
ParidaP,YadavRNS, 2012.Comparative docking study of m1 protein (influenza virus) to check drug efficacy,Int J Pharm Pharm Sci 4 243 -46
PatilR,DasS,StanleyA,YadavL,SudhakarA,VarmaAK, 2010.Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing,PLoS ONE 5 e12029 -
0

Citations

0

Downloads

107

Views